ÂÜÀòÂÒÂ×

Audrey Greenberg is a seasoned entrepreneur and board member with extensive experience in the biopharmaceutical and real estate sectors. Currently serving as the Founder of SK pharmteco and the Center for Breakthrough Medicines, Audrey has been instrumental in providing comprehensive CDMO services and advancing cell and gene therapy solutions. As a board member for various organizations, including the Abramson Cancer Center Innovation Advisory Board, New York Mortgage Trust, Inc., and NLS Pharmaceutics AG, Audrey contributes to strategic initiatives in healthcare and finance. Audrey is also actively engaged in the Young Presidents Organization, sharing insights with fellow executives to foster leadership and innovation. Audrey holds an MBA in Finance and Management from The Wharton School and a BSBA in Accounting and Finance from the University of Arizona.